Madrigal Pharmaceuticals (MDGL) Change in Inventory (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has reported Change in Inventory for 3 consecutive years, with $11.5 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Inventory rose 38.83% year-over-year to $11.5 million; the TTM figure through Jun 2026 stood at $41.2 million (down 26.99% YoY), while the FY2025 annual figure was $37.0 million, up 8.54% from the prior year.
• Change in Inventory retreated to $11.5 million in Q2 2026 per MDGL's latest filing, from $22.2 million in the prior quarter.
• Across five years, Change in Inventory topped out at $25.4 million in Q4 2024 and bottomed at $854000.0 in Q1 2024.
• Historically, Change in Inventory has averaged $10.5 million across 3 years, with a median of $7.2 million in 2024.
• On a YoY basis, Change in Inventory climbed as much as 2379.27% in 2025 and fell as far as 93.18% in 2025.
• Madrigal Pharmaceuticals' Change in Inventory stood at $25.4 million in 2024, then plunged by 93.18% to $1.7 million in 2025, then soared by 562.93% to $11.5 million in 2026.
• Business Quant data shows MDGL's Change in Inventory at $11.5 million in Q2 2026, $22.2 million in Q1 2026, and $1.7 million in Q4 2025.